Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Do you ever treat regional lymph nodes for malignant phyllodes tumor of the breast?
In what situations would you want to include regional nodes? Particular tumor size?
Answer from: Radiation Oncologist at Community Practice
I have not treated regional nodes in malignant phyllodes cases, even in larger tumors.
Sign In
or
Register
to read more
10764
Related Questions
In a patient with T2N0 breast cancer with skin involvement s/p lumpectomy and negative margins, if you are offering whole breast radiation, would you bolus your tangent fields?
How do you approach the discussion about the potential risks of radiation therapy exposure and the development of secondary malignancies for patients with germline BRCA1/2 mutations?
Is it reasonable to extrapolate the findings of RT Charm and Alliance to intact breast patients and offer hypofractionated RNI to all patients who are eligible for RNI?
What dose of reirradiation would you consider for locally recurrent breast cancer after mastectomy, excised with positive margins?
Given the 10-year outcomes of UK FAST-Forward presented at ESTRO, how have you expanded the use of ultra-hypofractionation in your practice?
When treating early stage breast cancer with adjuvant RT, what risk factors would lead you to include the level 1 and 2 axilla in patients with pN0(i+) disease?
When do you start adjuvant radiation with areas of delayed wound healing after reduction mammoplasty?
When treating chestwall + RNI with VMAT, how much do you crop the PTV into lung as is done with the PTVeval in 3D contouring guides?
Would you offer ultra-hypofractionated accelerated partial breast re-irradiation using 5 fractions?
Would you offer partial breast radiation to a young breast cancer patient with BRCA 1 if all other criteria are met?